Thomas M. Elliott

645 total citations
28 papers, 432 citations indexed

About

Thomas M. Elliott is a scholar working on Epidemiology, Oncology and Molecular Medicine. According to data from OpenAlex, Thomas M. Elliott has authored 28 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Oncology and 5 papers in Molecular Medicine. Recurrent topics in Thomas M. Elliott's work include Antibiotic Resistance in Bacteria (5 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Cutaneous Melanoma Detection and Management (5 papers). Thomas M. Elliott is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Cutaneous Melanoma Detection and Management (5 papers). Thomas M. Elliott collaborates with scholars based in Australia, United Kingdom and New Zealand. Thomas M. Elliott's co-authors include Louisa G. Gordon, David C. Whiteman, Catherine M. Olsen, Nirmala Pandeya, Patrick N. A. Harris, Xing J. Lee, David L. Paterson, Astrid J. Rodriguez‐Acevedo, Elizabeth D. Williams and Ian Vela and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and European Journal of Cancer.

In The Last Decade

Thomas M. Elliott

27 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas M. Elliott Australia	14	134	117	87	71	60	28	432
Francisca M. Marti United Kingdom	5	307 2.3×	76 0.6×	31 0.4×	13 0.2×	44 0.7×	20	371
Joaquín Borrás‐Blasco Spain	15	40 0.3×	110 0.9×	61 0.7×	21 0.3×	48 0.8×	61	618
Aurélie Gaultier France	13	279 2.1×	92 0.8×	100 1.1×	23 0.3×	116 1.9×	44	625
Karina Jahnz‐Różyk Poland	13	54 0.4×	160 1.4×	154 1.8×	35 0.5×	150 2.5×	114	781
L. Leibovici Israel	7	123 0.9×	130 1.1×	6 0.1×	10 0.1×	26 0.4×	8	386
Jennifer E. Schwartz United States	12	110 0.8×	55 0.5×	11 0.1×	4 0.1×	40 0.7×	37	513
Johnnie Yates United States	6	125 0.9×	18 0.2×	17 0.2×	23 0.3×	39 0.7×	11	361
Lauren Strazzula United States	8	66 0.5×	73 0.6×	97 1.1×	11 0.2×	17 0.3×	13	358
Sharon E. Parker United Kingdom	12	53 0.4×	89 0.8×	2 0.0×	29 0.4×	47 0.8×	17	469
Per Olov Hedlund Sweden	17	82 0.6×	93 0.8×	15 0.2×	8 0.1×	298 5.0×	53	714

Countries citing papers authored by Thomas M. Elliott

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Elliott more than expected).

Fields of papers citing papers by Thomas M. Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Elliott. The network helps show where Thomas M. Elliott may publish in the future.

Co-authorship network of co-authors of Thomas M. Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Elliott. A scholar is included among the top collaborators of Thomas M. Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Elliott. Thomas M. Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elliott, Thomas M., et al.. (2024). Steroid-induced mania in a patient with previously well-controlled organic bipolar 1-like affective disorder secondary to acquired brain injury: case report and literature review. SHILAP Revista de lepidopterología. 4(1). 8–8. 4 indexed citations

Lindsay, Daniel, et al.. (2024). Exploratory Cost-Utility Analysis of a 37-Gene Panel Versus Usual Care to Guide Therapy for Patients with Intermediate-Risk Myeloid Malignancies. Applied Health Economics and Health Policy. 23(3). 507–517.

Gordon, Louisa G., William Leung, Richard J. Johns, et al.. (2022). Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021. International Journal of Environmental Research and Public Health. 19(6). 3178–3178. 35 indexed citations

Elliott, Thomas M., et al.. (2021). Unexpected benefit of COVID-19 hospital restrictions: Reduction in patients isolating with multidrug resistant organisms after restrictions were lifted. Infection Disease & Health. 27(1). 10–14. 5 indexed citations

Elliott, Thomas M., Patrick N. A. Harris, Leah W. Roberts, et al.. (2021). Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistantAcinetobacter baumannii. SHILAP Revista de lepidopterología. 1(1). e62–e62. 9 indexed citations

Gordon, Louisa G., Thomas M. Elliott, Brian M. Forde, et al.. (2021). Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia. BMJ Open. 11(2). e041968–e041968. 28 indexed citations

Gordon, Louisa G., Catherine M. Olsen, David C. Whiteman, et al.. (2020). Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study. BMJ Open. 10(2). e034388–e034388. 23 indexed citations

Elliott, Thomas M., et al.. (2020). Evaluating the economic effects of genomic sequencing of pathogens to prioritise hospital patients competing for isolation beds. Australian Health Review. 45(1). 59–65. 5 indexed citations

Gordon, Louisa G., Nicole White, Thomas M. Elliott, et al.. (2020). Estimating the costs of genomic sequencing in cancer control. BMC Health Services Research. 20(1). 492–492. 37 indexed citations

10.

Gordon, Louisa G., Thomas M. Elliott, Michael Michael, et al.. (2020). The Economic Impact on Australian Patients with Neuroendocrine Tumours. Patient. 13(3). 363–373. 15 indexed citations

11.

Elliott, Thomas M., et al.. (2020). A hybrid simulation model approach to examine bacterial genome sequencing during a hospital outbreak. BMC Infectious Diseases. 20(1). 72–72. 14 indexed citations

12.

Rodriguez‐Acevedo, Astrid J., Xing J. Lee, Thomas M. Elliott, & Louisa G. Gordon. (2020). Hospitalization costs for patients colonized with carbapenemase-producing Enterobacterales during an Australian outbreak. Journal of Hospital Infection. 105(2). 146–153. 15 indexed citations

13.

Gordon, Louisa G., et al.. (2020). Exploratory cost-effectiveness analysis of 68Gallium-PSMA PET/MRI-based imaging in patients with biochemical recurrence of prostate cancer. Clinical & Experimental Metastasis. 37(2). 305–312. 31 indexed citations

14.

Lee, Xing J., Thomas M. Elliott, Patrick N. A. Harris, et al.. (2020). Clinical and Economic Outcomes of Genome Sequencing Availability on Containing a Hospital Outbreak of Resistant Escherichia coli in Australia. Value in Health. 23(8). 994–1002. 13 indexed citations

15.

Roberts, Matthew J., Alastair Macdonald, Patrick Telöken, et al.. (2020). Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate Cancer and Prostatic Diseases. 24(1). 169–176. 21 indexed citations

16.

Gordon, Louisa G., Thomas M. Elliott, Catherine M. Olsen, Nirmala Pandeya, & David C. Whiteman. (2018). Out‐of‐pocket medical expenses for Queenslanders with a major cancer. The Medical Journal of Australia. 208(11). 497–497. 16 indexed citations

17.

Elliott, Thomas M., David C. Whiteman, Catherine M. Olsen, & Louisa G. Gordon. (2017). Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis. Applied Health Economics and Health Policy. 15(6). 805–816. 58 indexed citations

18.

Gordon, Louisa G., Thomas M. Elliott, Catherine M. Olsen, Nirmala Pandeya, & David C. Whiteman. (2017). Multiplicity of skin cancers in Queensland and their cost burden to government and patients. Australian and New Zealand Journal of Public Health. 42(1). 86–91. 24 indexed citations

19.

Gordon, Louisa G., et al.. (2016). Modelling the healthcare costs of skin cancer in South Africa. BMC Health Services Research. 16(1). 113–113. 28 indexed citations

20.

Mansour, Salah, Lyndsey Goulston, Joseph P. Sanderson, et al.. (2014). iNKT cell dysfunction in early rheumatoid arthritis is associated with a qualitative shift in the iNKT cell receptor repertoire. Immunology. 143. 166–166. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact